Juhani Knuuti
MD, professor, Turku PET Centre
jknuuti@utu.fi +358 29 450 2345 +358 50 059 2998 Kiinamyllynkatu 4-8 Turku ORCID-tunniste: https://orcid.org/0000-0003-3156-9593 |
Cardiovascular diseases, imaging
Juhani Knuuti’s research has focused on the physiology and pathophysiology, diagnosis and new therapies of coronary artery disease, heart failure and metabolic diseases. The research is also focused on developing and utilizing novel noninvasive imaging methods (PET, SPECT, echocardiography, MRI and CT) that will help to determine the risk and severity of CHD and heart failure and provide guidance for therapy decisions. The recent focus in cardiac research has been on vulnerable plaques, cardiac remodelling and multimodality and hybrid imaging. In metabolic and diabetes research, the focus has been in the interactions between different organs and heart in the pathogenesis and development of the cardiac diseases.
- The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease (2006)
- Journal of Inherited Metabolic Disease
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - The effect of PPARgamma-agonism on LDL subclass profile in patients with type 2 diabetes and coronary artery disease (2006)
- The Review of Diabetic Studies
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - The future of cardiovascular imaging and non-invasive diagnosis - A joint statement from the European Association of Echocardiography, the Working Groups on Cardiovascular Magnetic Resonance, Computers in Cardiology, and Nuclear Cardiology of the European Society of Cardiology, the European Association of Nuclear Medicine and the Association for European Paediatric Cardiology (2006)
- European Journal of Echocardiography
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - The future of cardiovascular imaging and non-invasive diagnosis - A joint statement from the European Association of Echocardiography, the Working Groups on Cardiovascular Magnetic Resonance, Computers in Cardiology, and Nuclear Cardiology, of the European Society of Cardiology, the European Association of Nuclear Medicine and the Association for European Paediatric Cardiology (2006)
- European Journal of Nuclear Medicine and Molecular Imaging
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - The future of cardiovascular imaging and non-invasive diagnosis - A joint statement from the European Association of Echocardiography, the Working Groups on Cardiovascular Magnetic Resonance, Computers in Cardiology, and Nuclear Cardiology, of the European Society of Cardiology, the European Association of Nuclear Medicine, and the Association for European Paediatric Cardiology (2006)
- European Heart Journal
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - The influence of hepatic lipase C-480T polymorphism on coronary flow reserve in young men is independent of the plasma cholesterol level (2006)
- Atherosclerosis
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - The regulatory background of nuclear cardiology in Europe: a survey by the European Council of Nuclear Cardiology (2006)
- European Journal of Nuclear Medicine and Molecular Imaging
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Utility of I-123-MIBG scintigraphy in subjects with heart failure for assessment of risk for a major cardiac event: A European multi-center study (2006)
- Circulation
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - An autoradiographic study of [F-18]FDG uptake to islets of Langerhans in NOD mouse (2005)
- Diabetes Research and Clinical Practice
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Cardiac function and efficiency are dependent on free fatty acid availibility in patients with idiopathic dilated cardiomyopathy and heart failure (2005)
- Circulation
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Cardiac resynchronization therapy - Part 1 - Issues before device implantation (2005)
- Journal of the American College of Cardiology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Cardiac resynchronization therapy - Part 2 - Issues during and after device (2005)
- Journal of the American College of Cardiology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology (2005)
- European Journal of Nuclear Medicine and Molecular Imaging
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Efficacy of bioabsorbable antibiotic containing bone screw in the prevention of biomaterial-related infection due to Staphylococcus aureus (2005)
- BONE
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filter for treatment of experimental osteomyelitis due to Staphylococcus aureus (2005)
- Antimicrobial Agents and Chemotherapy
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Evaluation of Hepatic Fatty Acid Handling and Triglyceride Release in the Blood Stream Using C-11-Palmitate during Fasting and Euglicemic Hyperinsulinemia (2005)
- European Journal of Nuclear Medicine and Molecular Imaging
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Free Fatty Acid Biodistribution and Triglyceride Metabolism Using the Fatty Acid Analogue 18F-FTHA during Fasting and Hyperinsulinemia (2005)
- European Journal of Nuclear Medicine and Molecular Imaging
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Imaging of Oxidative Metabolism: Insight into cardiac performance (Marie Curie Lecture) (2005)
- European Journal of Nuclear Medicine and Molecular Imaging
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes - A positron-emitting tomography study (2005)
- Diabetes
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Increased lipoprotein(a) is associated with reduced myocardial vasoreactivity in young healthy men (2005)
- Atherosclerosis
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )